-
Orbit Genomics At BIO International Convention
Orbit Genomics CEO & Co-Founder Dede Willis was invited to speak at the BIO International Convention as a panelist for Patents in the Crosshairs: Confronting a Coordinated Assault on Intellectual Property. The panel brought together leaders from the Biotechnology Innovation Organization (BIO), Genentech, Capitol Street, and the Council for Innovation Promotion to discuss the critical…
-
Orbit Genomics Presents AI-Enabled Blood Test for Lung Cancer Diagnosis and Subtyping
Orbit Genomics presented new data on its blood-based lung cancer diagnostic platform at the Labroots Precision Medicine: Genomics, Proteomics & Molecular Diagnostics Virtual Event Series 2026. The poster, “AI-Enabled Blood Test for Accurate Diagnosis and Subtyping Lung Cancer,” describes Orbit Genomics’ work to develop a blood-based diagnostic test for indeterminate pulmonary nodules (IPNs) while expanding…
-
Orbit Genomics Wins Startup Prize Focus on Health (Non-FDA Track)
Orbit Genomics today announced that it is the grand prize winner of the Startup Prize Focus on Health 2025 in the Non-FDA track, a nationally recognized competition spotlighting transformative innovation in healthcare and life sciences. Selected from a record-breaking pool of 75 startups across 23 states, Orbit Genomics was recognized for its patented OrbiSeq™ platform,…